Stephen Bush, MD; Todd DePond, MD; Karinna Andrews, DO and Emily Montgomery, MD, with CAMC Obstetrics and Gynecology at Women and Children’s Hospital, are the only Ob-Gyn’s in West Virginia offering the Sonata® Treatment for women suffering from debilitating symptoms caused by uterine
Sonata Treatment and the Future of FemTech
Maneesha Ghiya of FemHealth Ventures talks with CNBC's Women & Wealth to discuss the optimistic future of FemTech. Ghiya shares how nearly dying from complications after childbirth prompted her to create FemHealth Ventures to be a vehicle for funding better diagnostics, research, and treatments
Minimally Invasive Sonata Treatment for Uterine Fibroids Now Offered in Kentucky
Women in the Kentucky area now have an innovative solution for managing heavy periods caused by symptomatic uterine fibroids. Dr. Mark Hoffman and the University of Kentucky have embraced the Sonata Treatment, joining a growing community of physicians offering this minimally invasive alternative to
Gynesonics Announces New Category 1 CPT Code for its Sonata Transcervical RF Ablation Procedure Used to Treat Uterine Fibroids
REDWOOD CITY, Calif., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Gynesonics®, Inc. a privately-held women’s healthcare medical device company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today that with the support of the American College of
Gynesonics to announce completion of latest funding round soon, new CEO says
Originally published by Mergermarket 25 Oct 2023 17:55 EDT Gynesonics, a Redwood City, California-based women’s healthcare and medical device company, plans to announce the completion of a significant financing round soon, said new CEO Skip Baldino. The company announced a USD 25m financing
Gynesonics’ Incision-Free Sonata Procedure for the Treatment of Uterine Fibroids Reaches Patient Milestones in the U.S. and Globally
REDWOOD CITY, Calif., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Gynesonics®, Inc. a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, is pleased to announce that its Sonata® Procedure has been used to treat over 1,000 women in the United
SSM Medical Minute on Fox 2 News Talks Uterine Fibroid Treatment with Sonata TFA
Dr. Brigid Holleran-Schwartz of SSM Health, talks with Fox 2 News in St. Louis, MO. about the Sonata Treatment. The Sonata Treatment is an incisionless solution clinically proven to reduce fibroid symptoms including heavy menstrual bleeding. This treatment can address a wide range of fibroid types
Stony Brook Medicine’s Patient Shares How Sonata Improved Her Quality of Life
Donna Febo, a patient of Stony Brook Medicine in New York, thought her heavy bleeding and pelvic pain were caused by her body approaching menopause until talking with her doctor and identifying two fibroids. Hear Donna talk about how the minimally invasive approach of Sonata Fibroid Treatment helped